221 related articles for article (PubMed ID: 1572089)
1. The profile of IgG and IgG subclasses of onchocerciasis patients.
Dafa'alla TH; Ghalib HW; Abdelmageed A; Williams JF
Clin Exp Immunol; 1992 May; 88(2):258-63. PubMed ID: 1572089
[TBL] [Abstract][Full Text] [Related]
2. Human onchocerciasis in Nigeria: isotypic responses and antigen recognition in individuals with defined cutaneous pathology.
Murdoch ME; Abiose A; Garate T; Hay RJ; Jones BR; Maizels RM; Parkhouse RM
Am J Trop Med Hyg; 1996 Jun; 54(6):600-12. PubMed ID: 8686779
[TBL] [Abstract][Full Text] [Related]
3. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of
Cama VA; McDonald C; Arcury-Quandt A; Eberhard M; Jenks MH; Smith J; Feleke SM; Abanyie F; Thomson L; Wiegand RE; Cantey PT
Am J Trop Med Hyg; 2018 Oct; 99(4):1041-1048. PubMed ID: 30062989
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus.
Gbakima AA; Nutman TB; Bradley JE; McReynolds LA; Winget MD; Hong Y; Scott AL
Clin Diagn Lab Immunol; 1996 Jan; 3(1):98-104. PubMed ID: 8770512
[TBL] [Abstract][Full Text] [Related]
6. Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33).
Lucius R; Kern A; Seeber F; Pogonka T; Willenbücher J; Taylor HR; Pinder M; Ghalib HW; Schulz-Key H; Soboslay P
Trop Med Parasitol; 1992 Sep; 43(3):139-45. PubMed ID: 1281926
[TBL] [Abstract][Full Text] [Related]
7. Associations between clinical disease, circulating antibodies and C1q-binding immune complexes in human onchocerciasis.
Sisley BM; Mackenzie CD; Steward MW; Williams JF; O'Day J; Luty AJ; Braga M; el Sheikh H
Parasite Immunol; 1987 Jul; 9(4):447-63. PubMed ID: 3498141
[TBL] [Abstract][Full Text] [Related]
8. Antibody isotypes, including IgG subclasses, in Ecuadorian patients with pulmonary paragonimiasis.
Guevara A; Vieira JC; Araujo E; Calvopiña M; Guderian RH; Carlier Y
Mem Inst Oswaldo Cruz; 1995; 90(4):497-502. PubMed ID: 8551951
[TBL] [Abstract][Full Text] [Related]
9. Strong IgG isotypic antibody response in sowdah type onchocerciasis.
Brattig NW; Krawietz I; Abakar AZ; Erttmann KD; Kruppa TF; Massougbodji A
J Infect Dis; 1994 Oct; 170(4):955-61. PubMed ID: 7930741
[TBL] [Abstract][Full Text] [Related]
10. Analysis of IgG isotype responses against Onchocerca volvulus antigens in children in an onchocerciasis-endemic area in northern Nigeria.
Enwezor FN; Nock IH; Edeghere H; Idowu BT; Osue HO; Engelbrecht F
Ann Trop Paediatr; 2000 Jun; 20(2):141-6. PubMed ID: 10945066
[TBL] [Abstract][Full Text] [Related]
11. Changes in antibody profile after treatment of human onchocerciasis.
Lee SJ; Francis HL; Awadzi K; Ottesen EA; Nutman TB
J Infect Dis; 1990 Aug; 162(2):529-33. PubMed ID: 2197344
[TBL] [Abstract][Full Text] [Related]
12. IgG4 subclass antibody serology for onchocerciasis.
Weil GJ; Ogunrinade AF; Chandrashekar R; Kale OO
J Infect Dis; 1990 Mar; 161(3):549-54. PubMed ID: 2179425
[TBL] [Abstract][Full Text] [Related]
13. Anti-Onchocerca volvulus immunoglobulin subclass response in children from Sierra Leone.
Gbakima AA; Ibrahim MS; Scott AL
Scand J Immunol Suppl; 1992; 11():53-6. PubMed ID: 1514051
[TBL] [Abstract][Full Text] [Related]
14. Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients.
Tawill SA; Gallin M; Erttmann KD; Kipp W; Bamuhiiga J; Büttner DW
Trans R Soc Trop Med Hyg; 1996; 90(1):85-9. PubMed ID: 8730320
[TBL] [Abstract][Full Text] [Related]
15. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Onchocerca volvulus-specific IgG4 subclass serology as an index of onchocerciasis transmission potential of three Gabonese villages.
Egwang TG; Duong TH; Nguiri C; Ngari P; Everaere S; Richard-Lenoble D; Gbakima AA; Kombila M
Clin Exp Immunol; 1994 Dec; 98(3):401-7. PubMed ID: 7994904
[TBL] [Abstract][Full Text] [Related]
17. Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulus.
Soboslay PT; Weiss N; Dreweck CM; Taylor HR; Brotman B; Schulz-Key H; Greene BM
Exp Parasitol; 1992 Jun; 74(4):367-80. PubMed ID: 1592090
[TBL] [Abstract][Full Text] [Related]
18. Guatemalan human onchocerciasis. II. Evidence for IgG3 involvement in acquired immunity to Onchocerca volvulus and identification of possible immune-associated antigens.
Boyer AE; Tsang VC; Eberhard ML; Zea-Flores G; Hightower A; Pilcher JB; Zea-Flores R; Zhou W; Reimer CB
J Immunol; 1991 Jun; 146(11):4001-10. PubMed ID: 2033268
[TBL] [Abstract][Full Text] [Related]
19. Onchocerca ochengi acquisition in zebu Gudali cattle exposed to natural transmission: parasite population dynamics and IgG antibody subclass responses to Ov10/Ov11 recombinant antigens.
Achukwi MD; Harnett W; Bradley J; Renz A
Vet Parasitol; 2004 Jun; 122(1):35-49. PubMed ID: 15158555
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Diagnostic Performance of
Lagatie O; Verheyen A; Nijs E; Van Dorst B; Batsa Debrah L; Debrah A; Supali T; Sartono E; Stuyver LJ
Am J Trop Med Hyg; 2018 Mar; 98(3):779-785. PubMed ID: 29313477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
